跳至主要内容
临床试验/IRCT201607034105N17
IRCT201607034105N17已完成未知

The effects of consumption of Lactobacillus Casei on glycemic factors, and serum sirtuin1 and fetuin-A levels in type 2 diabetic patients: A controlled clinical trial.

Research Department of Tabriz University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65 years 至 45 years(—)
性别
All

入选标准

  • Patients with diabetes for more than a year of developing diabetes and over 6 months pass the use of glucose lowering drugs ; Age 30 to 50 years. Exclusion criteria: Insulin injections; BMI> 35 Kg / m2; smoking; breastfeeding and pregnancy; menopause; using antibiotics and anti-inflammatory drugs within a month before and during the intervention; chronic digestive problems, and acute gastrointestinal problems within a month before and during the intervention; infectious and inflammatory diseases; Get any supplements.

排除标准

  • 未提供

研究者

发起方
Research Department of Tabriz University of Medical Sciences

相似试验